Hikma Pharmaceuticals Plc Stock Probability of Future Pink Sheet Price Finishing Over 50.31
| HKMPY Stock | USD 50.32 0.51 1.02% |
Hikma |
Hikma Pharmaceuticals Target Price Odds to finish over 50.31
The tendency of Hikma Pink Sheet price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to stay above $ 50.31 in 90 days |
| 50.32 | 90 days | 50.31 | about 35.93 |
Based on a normal probability distribution, the odds of Hikma Pharmaceuticals to stay above $ 50.31 in 90 days from now is about 35.93 (This Hikma Pharmaceuticals PLC probability density function shows the probability of Hikma Pink Sheet to fall within a particular range of prices over 90 days) . Probability of Hikma Pharmaceuticals PLC price to stay between $ 50.31 and its current price of $50.32 at the end of the 90-day period is near 1 .
Assuming the 90 days horizon Hikma Pharmaceuticals has a beta of 0.52. This usually indicates as returns on the market go up, Hikma Pharmaceuticals average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Hikma Pharmaceuticals PLC will be expected to be much smaller as well. Additionally Hikma Pharmaceuticals PLC has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Hikma Pharmaceuticals Price Density |
| Price |
Predictive Modules for Hikma Pharmaceuticals
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Hikma Pharmaceuticals PLC. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Hikma Pharmaceuticals Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Hikma Pharmaceuticals is not an exception. The market had few large corrections towards the Hikma Pharmaceuticals' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Hikma Pharmaceuticals PLC, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Hikma Pharmaceuticals within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.06 | |
β | Beta against Dow Jones | 0.52 | |
σ | Overall volatility | 1.86 | |
Ir | Information ratio | -0.07 |
Hikma Pharmaceuticals Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Hikma Pharmaceuticals for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Hikma Pharmaceuticals PLC can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Hikma Pharmaceuticals generated a negative expected return over the last 90 days |
Hikma Pharmaceuticals Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Hikma Pink Sheet often depends not only on the future outlook of the current and potential Hikma Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Hikma Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 118 M | |
| Cash And Short Term Investments | 426 M |
Hikma Pharmaceuticals Technical Analysis
Hikma Pharmaceuticals' future price can be derived by breaking down and analyzing its technical indicators over time. Hikma Pink Sheet technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Hikma Pharmaceuticals PLC. In general, you should focus on analyzing Hikma Pink Sheet price patterns and their correlations with different microeconomic environments and drivers.
Hikma Pharmaceuticals Predictive Forecast Models
Hikma Pharmaceuticals' time-series forecasting models is one of many Hikma Pharmaceuticals' pink sheet analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Hikma Pharmaceuticals' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the pink sheet market movement and maximize returns from investment trading.
Things to note about Hikma Pharmaceuticals PLC
Checking the ongoing alerts about Hikma Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Hikma Pharmaceuticals PLC help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Hikma Pharmaceuticals generated a negative expected return over the last 90 days |
Additional Tools for Hikma Pink Sheet Analysis
When running Hikma Pharmaceuticals' price analysis, check to measure Hikma Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hikma Pharmaceuticals is operating at the current time. Most of Hikma Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Hikma Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hikma Pharmaceuticals' price. Additionally, you may evaluate how the addition of Hikma Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.